p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription

FEBS Letters

Volumn 579, Issue 5, 2005, Pages 1001-1007

  Innocente, Steven A ^a   Lee, Jonathan M ^a,b,c  

^a JURAVINSKI CANCER CENTRE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cell cycle; Cyclin B1; p53; Sp1; Transcription repression

Indexed keywords

CYCLIN B1; NUCLEAR FACTOR Y; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE SEGREGATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WILD TYPE;

EID: 13844280115     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2004.12.073     Document Type: Article

References (42)

1. S.A. Innocente, J.L. Abrahamson, J.P. Cogswell, and J.M. Lee p53 regulates a G2 checkpoint through cyclin B1 Proc. Natl. Acad. Sci. USA 96 1999 2147 2152
2. L.H. Hartwell, and T.A. Weinert Checkpoints: controls that ensure the order of cell cycle events Science 246 1989 629 634
3. P. Fei, and W.S. elDeiry P53 and radiation responses Oncogene 22 2003 5774 5783
4. C.J. Sherr Cancer cell cycles Science 274 1996 1672 1677
5. R. Ohi, and K.L. Gould Regulating the onset of mitosis Curr. Opin. Cell Biol. 11 1999 267 273
6. L.A. Porter, and D.J. Donoghue Cyclin B1 and CDK1: nuclear localization and upstream regulators Prog. Cell Cycle Res. 5 2003 335 347
7. G. Draetta, F. Luca, J. Westendorf, L. Brizuela, J. Ruderman, and D. Beach Cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF Cell 56 1989 829 838
8. J. Pines, and T. Hunter Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2 Cell 58 1989 833 846
9. J.P. Cogswell, M.M. Godlevski, M. Bonham, J. Bisi, and L. Babiss Upstream stimulatory factor regulates expression of the cell cycle-dependent cyclin B1 gene promoter Mol. Cell Biol. 15 1995 2782 2790
10. K.S. Katula, K.L. Wright, H. Paul, D.R. Surman, F.J. Nuckolls, J.W. Smith, J.P. Ting, J. Yates, and J.P. Cogswell Cyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elements Cell Growth Differ. 8 1997 811 820
11. C. Chu, J. Cogswell, and D.S. Kohtz MyoD functions as a transcriptional repressor in proliferating myoblasts J. Biol. Chem. 272 1997 3145 3148
12. W.S. elDeiry, S.E. Kern, J.A. Pietenpol, K.W. Kinzler, and B. Vogelstein Definition of a consensus binding site for p53 Nat. Genet. 1 1992 45 49
13. W.S. elDeiry, T. Tokino, T. Waldman, J.D. Oliner, V.E. Velculescu, M. Burrell, D.E. Hill, E. Healy, J.L. Rees, and S.R. Hamilton Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues Cancer Res. 55 1995 2910 2919
14. M.B. Kastan, Q. Zhan, W.S. el-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J.J. Fornace A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia- telangiectasia Cell 71 1992 587 597
15. H. Hermeking, C. Lengauer, K. Polyak, T.C. He, L. Zhang, S. Thiagalingam, K.W. Kinzler, and B. Vogelstein 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression Mol. Cell 1 1997 3 11
16. T.A. Chan, P.M. Hwang, H. Hermeking, K.W. Kinzler, and B. Vogelstein Cooperative effects of genes controlling the G(2)/M checkpoint Genes Dev. 14 2000 1584 1588
17. T.A. Chan, H. Hermeking, C. Lengauer, K.W. Kinzler, and B. Vogelstein 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage Nature 401 1999 616 620
18. J. Ho, and S. Benchimol Transcriptional repression mediated by the p53 tumour suppressor Cell Death Differ. 10 2003 404 408
19. C. Koumenis, R. Alarcon, E. Hammond, P. Sutphin, W. Hoffman, M. Murphy, J. Derr, Y. Taya, S.W. Lowe, M. Kastan, and A. Giaccia Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation Mol. Cell Biol. 21 2001 1297 1310
20. M. Murphy, J. Ahn, K.K. Walker, W.H. Hoffman, R.M. Evans, A.J. Levine, and D.L. George Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a Genes Dev. 13 1999 2490 2501
21. W.H. Hoffman, S. Biade, J.T. Zilfou, J. Chen, and M. Murphy Transcriptional repression of the anti-apoptotic survivin gene by wild type p53 J. Biol. Chem. 277 2002 3247 3257
22. K.C. Lee, A.J. Crowe, and M.C. Barton p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding Mol. Cell Biol. 19 1999 1279 1288
23. B. Li, and M.Y. Lee Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1 J. Biol. Chem. 276 2001 29729 29739
24. F. Vikhanskaya, E. Erba, M. D'Incalci, and M. Broggini Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53 Nucleic Acids Res. 22 1994 1012 1017
25. F.H. Brembeck, and A.K. Rustgi The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 and Sp1 J. Biol. Chem. 275 2000 28230 28239
26. W.R. Taylor, A.H. Schonthal, J. Galante, and G.R. Stark p130/E2F4 binds to and represses the cdc2 promoter in response to p53 J. Biol. Chem. 276 2001 1998 2006
27. P.W. Hinds, S. Mittnacht, V. Dulic, A. Arnold, S.I. Reed, and R.A. Weinberg Regulation of retinoblastoma protein functions by ectopic expression of human cyclins Cell 70 1992 993 1006
28. I. Manni, G. Mazzaro, A. Gurtner, R. Mantovani, U. Haugwitz, K. Krause, K. Engeland, A. Sacchi, S. Soddu, and G. Piaggio NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest J. Biol. Chem. 276 2001 5570 5576
29. W.R. Taylor, S.E. DePrimo, A. Agarwal, M.L. Agarwal, A.H. Schonthal, K.S. Katula, and G.R. Stark Mechanisms of G2 arrest in response to overexpression of p53 Mol. Biol. Cell 10 1999 3607 3622
30. M.S. Jung, J. Yun, H.D. Chae, J.M. Kim, S.C. Kim, T.S. Choi, and D.Y. Shin p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor Oncogene 20 2001 5818 5825
31. W.R. Taylor, and G.R. Stark Regulation of the G2/M transition by p53 Oncogene 20 2001 1803 1815
32. K. Krause, M. Wasner, W. Reinhard, U. Haugwitz, C.L. Dohna, J. Mossner, and K. Engeland The tumour suppressor protein p53 can repress transcription of cyclin B Nucleic Acids Res. 28 2000 4410 4418
33. J. Bargonetti, A. Chicas, D. White, and C. Prives p53 represses Sp1 DNA binding and HIV-LTR directed transcription Cell Mol. Biol. (Noisy.-le-grand). 43 1997 935 949
34. T. Kanaya, S. Kyo, K. Hamada, M. Takakura, Y. Kitagawa, H. Harada, and M. Inoue Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription Clin. Cancer Res. 6 2000 1239 1247
35. D. Xu, Q. Wang, A. Gruber, M. Bjorkholm, Z. Chen, A. Zaid, G. Selivanova, C. Peterson, K.G. Wiman, and P. Pisa Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells Oncogene 19 2000 5123 5133
36. G. Koutsodontis, I. Tentes, P. Papakosta, A. Moustakas, and D. Kardassis Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1). gene by the p53 tumor suppressor protein J. Biol. Chem. 276 2001 29116 29125
37. G. Lagger, A. Doetzlhofer, B. Schuettengruber, E. Haidweger, E. Simboeck, J. Tischler, S. Chiocca, G. Suske, H. Rotheneder, E. Wintersberger, and C. Seiser The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene Mol. Cell Biol. 23 2003 2669 2679
38. Y. Zhang, and M.L. Dufau Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB Mol. Cell Biol. 23 2003 6958 6972
39. K. Keyomarsi, and A.B. Pardee Redundant cyclin overexpression and gene amplification in breast cancer cells Proc. Natl. Acad. Sci. USA 90 1993 1112 1116
40. S. Takeno, T. Noguchi, R. Kikuchi, Y. Uchida, S. Yokoyama, and W. Muller Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma Cancer 94 2002 2874 2881
41. K.A. Hassan, K.K. Ang, A.K. ElNaggar, M.D. Story, J.I. Lee, D. Liu, W.K. Hong, and L. Mao Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma Cancer Res. 62 2002 6414 6417
42. M. Yasuda, F. Takesue, S. Inutsuka, M. Honda, T. Nozoe, and D. Korenaga Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological study J. Cancer Res. Clin. Oncol. 128 2002 412 416